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Abstract
The features of the clinical course of rotavirus infection in infants with perinatal exposure to HIV were studied. Serum level of
procalcitonin as a marker of inflammatory activity and the need for antimicrobial therapy was determined. The efficiency of the
proposed additions to basic treatment (low-lactose mixture for two months, antibiotic therapy in case of elevated procalcitonin
level) was demonstrated.
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Problem statement and analysis of the
recent research
According to estimates, about 220,000 Ukrainians are HIV-
positive. As of January 1, 2014, 3,287 HIV-infected children
at the age of 0-18 years were registered by health care in-
stitutions of Ukraine: 3,129 (95.2%) children were born to
HIV-infected mothers and 158 (4.8%) children were infected
in other ways (through unprotected sex, injection drug use,
other parenteral interventions). As of January 1, 2014, in
addition to HIV-positive children with confirmed status, there
were 6,915 children born to HIV-infected mothers with uncon-
firmed HIV status [4]. Children with perinatal HIV contact
are very vulnerable to infectious diseases, have longer and
severer recovery period, which can negatively affect their
development [8].
Rotavirus infection is very common among young chil-
dren. Approximately 50,000 children in Ukraine contract
intestinal infections annually. 25-50% of all cases of gas-
troenteritis in children under the age of 5 years are caused by
rotavirus infection (RVI). Rotavirus infection in children with
perinatal HIV exposure may result in severe clinical course
and complications. According to N. Kotova, HIV-negative
children born to HIV-positive mothers contract intestinal in-
fections significantly more often than children in the control
group [2, 3]. Probiotics may correct this condition but bi-
ologic drugs are prohibited for treatment of children with
undetermined HIV status [9, 10].
The objective of the research was to increase the effective-
ness of treatment of rotavirus intestinal infection in infants
with perinatal HIV exposure through the correction of the
nutritional status as well as the expansion of the range of diag-
nostic and therapeutic measures considering specific clinical
situation.
1. Materials and methods
There were examined 40 children with RVI at the age of 1-2
years (the average age was 18.2±3.5 months), born to HIV-
infected mothers. The following laboratory tests were made:
complete blood count, biochemical profile (determination
of serum levels of K, Na, Cl, glucose, total bilirubin, frac-
tions, urea, and creatinine), scatoscopy, stool culture to detect
pathogenic bacteria, the fecal pH, PCR for HIV, rota test and
PCR for rotavirus infection. Clinical stool samples were exam-
ined with Citotest Rota (Pharmasco) ELISA test-systems and
AmpliSens R© Rotavirus-EPh PCR kit, procalcitonin (PCT)
plasma concentration was determined using immunolumi-
nometric assay (B.R.A.H.M.S. Diagnostica, GmbH, Berlin,
Germany).
Children with clinical signs of rotavirus infection born to
HIV-infected mothers were divided into 2 groups of 20 per-
sons; their age, sex and severity of condition were considered.
Children of the main group received a low-lactose mixture,
antibiotic therapy as well as Smekta enterosorbent in addition
to basic therapy. The control group received only basic ther-
apy according to the protocol of diagnosis and treatment of
infectious secretory diarrhea in children [4]. According to the
protocol, basic therapy for this category of children included
rehydration therapy which was determined by the degree of
dehydration (Rehydron at a dose of 10 ml/kg orally after each
watery stool or vomiting; a 0.9% NaCl solution and a 5%
glucose solution in the ratio 1:1 at a dose of 50-100 mL/kg
intravenously), aluminosilicate sorbents for 5-7 days and a
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low-lactose diet [4].
2. Results and discussion
The study of clinical signs showed that 26 (65%) children had
a moderate and 14 (35%) children had a severe clinical course
of rotavirus infection. The mean duration of rotavirus infec-
tion clinical symptoms was as follows: vomiting – 2.9±0.77
days; diarrhea – 6.2±0.84 days. The increase in body tem-
perature to 38◦C was observed in 35 (87.5%) children with
the average duration of 4.2±1.11 days. The signs of poi-
soning such as weakness and lethargy were noticed in 39
(97.5%) children; the signs of anhydration persisted 3.6±0.69
days. Accordingly, children needed long-term intensive ther-
apy (3.2±0.71 days) and prolonged hospitalization (7.4±0.2
days).
The analysis of laboratory finding revealed that the level
of total serum protein ranged from 66.8±3.75 g/l and corre-
sponded to the lower limit of normal values; electrolyte levels
(K, Na, Cl) corresponded to the indicators of the age norm,
namely potassium level was 5.1±0.2 mmol/l (normal potas-
sium level - 4.14-5.75 mmol/l), sodium level was 136.2±2
mmol/l (normal sodium level - 133-141 mmol/l), chlorine
level – 101.2±2.1 mmol/l (normal chlorine level - 98-107
mmol/l). The average blood glucose level corresponded to
normal values being 4.6±0.4 mmol/l. The levels of total
bilirubin and its fractions were within the age norm: total
bilirubin – 14.1±0.7 mmol/l (normal values of total bilirubin -
8.5-20 mmol/l), the levels of urea and creatinine corresponded
to the normal range (3.3- 5.6 mmol/l and 18-35 mmol/l, re-
spectively).
A qualitative PCR test was used to detect HIV in children
born to HIV-positive mothers to determine their status at the
age of 18 months. The test was negative in all 40 children
(inclusion criterion). The rota test was made as screening one,
and its result (positive) was one of the inclusion criteria.
Rotavirus PCR was performed in both groups to confirm
the presence of rotavirus RNA in the stools of children in-
cluded in the study.
The level of plasma procalcitonin (PCT) was determined
as an inflammatory marker. This indicator is important in
the management of patients with acute intestinal infection
since it helps determine the need for antibiotics. According
to the protocol of treatment of secretory diarrhea in children
[4], antibiotic therapy is indicated only for children with im-
munodeficiency conditions up to 1 year of age; HIV-infected
children at the stage of AIDS. However, according to several
studies, the optimal indication for antibiotic administration is
procalcitonin level>0.4 ng/ml [1]. Similar (although not iden-
tical) thresholds are suggested by Schuetz et al. [1]. These
researchers believe that when the biomarker concentration is
less than 0.25 ng/ml there is no need for antibiotics. The use
of antibiotics is recommended at PCT blood level of 0.25-0.5
ng/ml. PCT level in the study group was 0.21-0.98 ng/mL.
Coprological examination of all children with RVI showed the
characteristic signs of maldigestion and malabsorption man-
ifested themselves as amylorrhea, steatorrhea, creatorrhoea
which probably were associated with the feeding pattern. The
stools were unformed, watery and mixed with mucus. Chil-
dren with rotavirus infection developed signs of lactase defi-
ciency — stool pH less than 5.5. Fecal cultures yielded no
growth.
To improve the nutritional status of children with perinatal
HIV exposure we suggested to supplement the diet of children
in the main group with a low-lactose mixture. Since they were
not nourished with mixtures and children of this age with
RVI are recommended a lactose free or low lactose diet we
used a feeding system for younger children. To improve the
nutrition as well as to decrease the symptoms of secondary
lactase deficiency, children in the main group received 200 ml
of a low-lactose mixture twice a day for 2 months.
In addition to standard therapy (in PCT level above a
threshold of 0.4 ng/ml) a broad-spectrum antibiotic was pre-
scribed, namely third-generation cephalosporin – Ceftriaxone
at a dose of 80 mg/kg parenterally twice a day for 7 days.
Smekta enterosorbent was prescribed orally, 1 sachet of
3g once a day for 7 days. This is an antidiarrheal agent;
aluminosilicate of natural origin with a strong adsorption
effect.
Within two months we examined the dynamics of anthro-
pometric parameters, the indicators of blood and urine tests in
children with perinatal HIV exposure in both groups depend-
ing on the feeding type. At the beginning and at the end of
the study we examined anthropometric indices (body weight,
body length, circumferences of chest, shoulder, and thigh)
both in absolute numbers and according to the centile charts,
as well as values of complete blood count (RBC, Hb, color
index). The results are presented in Table 1.
All children of the main group had a normal period of
adaptation to the new product, and its introduction to the diet
did not cause any functional disorders of the digestive system
or allergic reactions.
The comparison of anthropometricindicators of children in
the main group before and after introduction of the low-lactose
mixture showed a significant increase in both body weight
and height, as well as chest, shoulder and thigh circumference.
In children of the control group on the background of basic
diet, the increase in anthropometricindicators such as body
weight as well as chest, shoulder and thigh circumference was
slower; it did not influence their height being lower than in
the children of the main group. The evaluation of body weight
and height according to the centile charts corresponded to
P 25-50, while in the children of control group — within P
10-25.
Two months later there was no difference in such blood
values as RBC, Hb and color index. No difference was found
in urine specific gravity index which indicated normal renal
function in both groups.
Thus, the supplementation of basic treatment with a mix-
ture which is a source of proteins, polyunsaturatedfatty acids
and energy contributes to positive dynamics in the physical
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Table 1. Anthropometric and laboratory parameters in infants with perinatal HIV exposure after two months of taking a
low-lactose mixture, M±m
Index Main group (n=20) Control group (n=20)Before the
introduction of the
product
After the
introduction of the
product
Before the
introduction of the
product
2 months after the
introduction of the
product
RBC 3.98±0.07 4.01±0.05 3.97±0.07 3.99±0.06
Hb, g/l 119.89±0.80 121.82±0.40 119.33±1.00 119.81±1.00
Color index 0.88±0.01 0.91±0.01 0.87±0.01 0.88±0.01
Urine specific gravity 1014.89±0.87 1015.9±0.87 1016.22±0.58 1015.22±0.58
Height, cm 78.33±1.26 82.03±0.97 78.34±1.25 79.23±0.85
Weight, g 10127.78±380.49 11927.78±182.1 10142.22±268.69 10175.22±167.91
Chest circumference, cm 41.83±0.27 43.23±0.21 41.81±0.26 42.14±0.18
Shoulder circumference, cm 13.38±0.31 15.28±0.11 13.37±0.31 143.22±0.12
Thigh circumference, cm 22.81±0.66 24.68±0.44 22.87±0.63 23.26±0.38
development of children.
The data of comparative analysis of symptom duration
in children of the main group who received a low-lactose
mixture and antibiotics, and the patients of the control group
who received basic therapy only are presented in Table 2.
In the main group of children with perinatal HIV contact,
there were 8 children with PCT level above a threshold of 0.4
ng/ml (which could signify mixed infection - bacterial flora
joining) and in the control group, there were 7 children with
PCT level above a threshold of 0.4 ng/ml. The comparison of
PCT data found that the clinical symptoms of acute intestinal
infection reduced significantly faster in children who received
antibiotic therapy.
The follow-up observation and study of the main com-
plaints of children with RVI was conducted within two months
from the onset of illness. In children of the main group a sig-
nificant reduction in complaints was noticed by the end of
the 1st month of the follow-up observation. The restoration
of appetite in 92.3% of children was noticed within the 2nd
month of the observation (p=0.02). Recurrent abdominal pain
and its equivalent, as well as functional intestinal disorders
in the form of unstable stool were recorded within the 2nd
month; however, a significant reduction in these symptoms
was observed during the 2nd month of the observation as well
(p=0.007).
3. Conclusions
• The prescription of the low-lactose mixture to young
children with perinatal HIV exposure for 2 months can
improve their physical development.
• PCT level above a threshold of 0.4 ng/ml as a marker
of the process of bacterial inflammation in the body
can be used as an indication for antibiotic therapy in
young children with perinatal HIV exposure in rotavirus
infection.
4. Prospects for further research
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